• Je něco špatně v tomto záznamu ?

The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia

M. Bucek Psenkova, L. Hlavinkova, M. Visnansky, D. Grega, M. Ondrusova

. 2024 ; 39 (-) : 14-19. [pub] 20231114

Jazyk angličtina Země Spojené státy americké

Typ dokumentu systematický přehled, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007801

OBJECTIVES: We have developed a scientifically well-grounded, methodological, and reporting checklist for economic evaluation (EE) of medicines in the Slovak health technology assessment process, which serves as a supplement to the Slovak pharmacoeconomic guidelines. METHODS: The checklist was developed using an iterative process in which items were generated and gradually added to the baseline checklist based on shortcomings identified in an analysis of Slovak EEs, using relevant published checklists, and Slovak, as well as international, methodological guidance that was identified in the systematic literature review. The selection of checklist recommendations, their clarity, and relevance to the Slovak setting were validated in the online survey. RESULTS: From the sample of 151 price and reimbursement submissions published between January 2018 and July 2021, almost half of them (n = 73) received at least 1 request from the Ministry of Healthcare to justify or modify the methodology used in the EE; and in 18 proceedings, a negative opinion was issued because of shortcomings identified in the EE. The 25-items preliminary checklist, resulting from an iterative working process, has been validated in an online survey conducted among members of ISPOR Chapter Slovakia. After incorporating relevant comments, the final proposal for the Slovak checklist consists of 55 recommendations. CONCLUSIONS: The research represented the first attempt to create a Slovak EE checklist, which serves as a part of ISPOR Slovakia pharmacoeconomic guidelines. Implementation of the checklist allows checking whether EE meets legislative and methodological requirements and thus helps in improving the appropriateness and standardization of EEs in Slovakia.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007801
003      
CZ-PrNML
005      
20240423160259.0
007      
ta
008      
240412e20231114xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.vhri.2023.09.003 $2 doi
035    __
$a (PubMed)37967490
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bucek Psenkova, Maria $u Pharm-In, Ltd., Bratislava, Slovakia. Electronic address: maria.bucekpsenkova@pharmin.sk
245    14
$a The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia / $c M. Bucek Psenkova, L. Hlavinkova, M. Visnansky, D. Grega, M. Ondrusova
520    9_
$a OBJECTIVES: We have developed a scientifically well-grounded, methodological, and reporting checklist for economic evaluation (EE) of medicines in the Slovak health technology assessment process, which serves as a supplement to the Slovak pharmacoeconomic guidelines. METHODS: The checklist was developed using an iterative process in which items were generated and gradually added to the baseline checklist based on shortcomings identified in an analysis of Slovak EEs, using relevant published checklists, and Slovak, as well as international, methodological guidance that was identified in the systematic literature review. The selection of checklist recommendations, their clarity, and relevance to the Slovak setting were validated in the online survey. RESULTS: From the sample of 151 price and reimbursement submissions published between January 2018 and July 2021, almost half of them (n = 73) received at least 1 request from the Ministry of Healthcare to justify or modify the methodology used in the EE; and in 18 proceedings, a negative opinion was issued because of shortcomings identified in the EE. The 25-items preliminary checklist, resulting from an iterative working process, has been validated in an online survey conducted among members of ISPOR Chapter Slovakia. After incorporating relevant comments, the final proposal for the Slovak checklist consists of 55 recommendations. CONCLUSIONS: The research represented the first attempt to create a Slovak EE checklist, which serves as a part of ISPOR Slovakia pharmacoeconomic guidelines. Implementation of the checklist allows checking whether EE meets legislative and methodological requirements and thus helps in improving the appropriateness and standardization of EEs in Slovakia.
650    _2
$a lidé $7 D006801
650    12
$a kontrolní seznam $7 D057189
650    12
$a ekonomika farmaceutická $7 D017850
651    _2
$a Slovenská republika $7 D018154
655    _2
$a systematický přehled $7 D000078182
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hlavinkova, Lucia $u Novo Nordisk Health Care AG, Zurich, Switzerland
700    1_
$a Visnansky, Martin $u University of Veterinary Medicine and Pharmacy, Kosice, Slovakia
700    1_
$a Grega, Dominik $u Pharm-In, Ltd., Bratislava, Slovakia; Department of Applied Pharmacy, Faculty of Pharmacy, Masaryk university, Brno, Czech Republic
700    1_
$a Ondrusova, Martina $u Pharm-In, Ltd., Bratislava, Slovakia; Department of Preventive and Clinical Medicine, Faculty of Public Health, Slovak Medical University, Bratislava, Slovakia
773    0_
$w MED00196873 $t Value in health regional issues $x 2212-1102 $g Roč. 39 (20231114), s. 14-19
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37967490 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160255 $b ABA008
999    __
$a ok $b bmc $g 2081661 $s 1217568
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 39 $c - $d 14-19 $e 20231114 $i 2212-1102 $m Value in health regional issues $n Value Health Reg Issues $x MED00196873
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Možnosti archivace